Results 101 to 110 of about 3,594 (173)

Do Not Throw Away Your Patient's Shot at Complete Vomiting Control. [PDF]

J Pediatr Pharmacol Ther
Dupuis LL, Patel P.
europepmc   +1 more source

Olanzapine Versus Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Sarma I, Buragohain S, Lahon J, Banerjee P, Kumar S, Chetia R, Baishya P, Saikia D.   +7 more
europepmc   +1 more source

Evidence-Based Perioperative Prevention of Postoperative Nausea and Vomiting (PONV) in Patients Undergoing Laparoscopic Bariatric Surgery: A Scoping Review. [PDF]

J Clin Med
Mieszczański P, Jurczak M, Cylke R, Ziemiański P, Trzebicki J.   +4 more
europepmc   +1 more source

Preventive and Therapeutic Interventions for Anticancer Drug-induced Dermatologic Toxicities: a Scoping Review. [PDF]

Curr Oncol Rep
Iimura Y, Kuroda S.
europepmc   +1 more source

Comparative Efficacy of Fosnetupitant and Fosaprepitant for Delayed Vomiting in Patients Receiving Irinotecan-Oxaliplatin Combination Chemotherapy: A Retrospective Propensity Score-Matched Study. [PDF]

Cancer Manag Res
Maeda K, Kawada K, Hayashi T, Koyama S, Ishida T, Yoshioka T, Fukuda H, Horikawa I, Aizawa F, Niimura T, Yagi K, Goda M, Izawa-Ishizawa Y, Ishizawa K.   +13 more
europepmc   +1 more source

Efficacy of steroid-omitting antiemetic therapy in patients with advanced pancreatic cancer receiving nano-liposomal irinotecan plus fluorouracil and leucovorin. [PDF]

Support Care Cancer
Tokito Y, Ishigaki K, Nara K, Endo G, Nishio H, Fukuda K, Suzuki T, Sato Y, Takahara N, Boku N, Fujishiro M.   +10 more
europepmc   +1 more source

Mas-Related G-Protein-Coupled Receptors: Emerging Roles in Neuropathic Pain. [PDF]

Biomolecules
García-Domínguez M.
europepmc   +1 more source

Refractory chronic lymphocytic leukemia-associated pruritus successfully treated with nemolizumab. [PDF]

JAAD Case Rep
Sellars IA, Jani Y, Cohen DJ.
europepmc   +1 more source

Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer. [PDF]

Sci Rep
Ghahremanloo A, Erfani B, Asgharzadeh F, Mansoori S, Gheybi F, Hashemy SI.   +5 more
europepmc   +1 more source

A Dual-Purpose Approach for an Anti-Emetic NK1R Antagonist as a Chemosensitizer and Cardioprotectant in a Preclinical Model of Triple-Negative Breast Cancer. [PDF]

Int J Mol Sci
Muñoz M, Coveñas R, Zuberi Y, Italia Z, Hoang T, Italia Z, Robinson P.   +6 more
europepmc   +1 more source